Ginkgo biloba for cognitive impairment and dementia
- 2 July 2020
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2020 (7)
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:Keywords
This publication has 49 references indexed in Scilit:
- Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trialsBMJ, 2011
- Ginkgo biloba for cognitive impairment and dementiaCochrane Database of Systematic Reviews, 2009
- Biology and chemistry of Ginkgo bilobaFitoterapia, 2008
- Ginkgo biloba for cognitive impairment and dementia2007
- Amyloid-β-Induced Pathological Behaviors Are Suppressed byGinkgo bilobaExtract EGb 761 and Ginkgolides in TransgenicCaenorhabditis elegansThe Journal of Neuroscience, 2006
- Protective effects of Ginkgo biloba extract against mercury(II)‐induced cardiovascular oxidative damage in ratsPhytotherapy Research, 2006
- Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive ImpairmentJournal of Internal Medicine, 2004
- Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical TrialsArchives of Neurology, 2004
- Evidence for toxic effects of alkylphenols from Ginkgo biloba in the hen's egg test (HET)Phytomedicine, 2001
- Effect of the extract of Ginkgo biloba (EGb 761) on the circulating and cellular profiles of polyunsaturated fatty acids: correlation with the anti-oxidant properties of the extractProstaglandins, Leukotrienes and Essential Fatty Acids, 2000